$10.77 Million in Sales Expected for Sharps Compliance Corp. (NASDAQ:SMED) This Quarter

Analysts expect Sharps Compliance Corp. (NASDAQ:SMED) to report sales of $10.77 million for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for Sharps Compliance’s earnings, with the highest sales estimate coming in at $10.92 million and the lowest estimate coming in at $10.60 million. Sharps Compliance reported sales of $9.91 million in the same quarter last year, which indicates a positive year over year growth rate of 8.7%. The firm is expected to issue its next earnings report before the market opens on Wednesday, August 21st.

According to Zacks, analysts expect that Sharps Compliance will report full year sales of $42.95 million for the current fiscal year, with estimates ranging from $42.90 million to $43.06 million. For the next year, analysts anticipate that the firm will report sales of $45.90 million, with estimates ranging from $45.20 million to $46.90 million. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side analysts that cover Sharps Compliance.

A number of research firms have weighed in on SMED. Roth Capital began coverage on Sharps Compliance in a report on Wednesday, July 24th. They set a “buy” rating and a $4.50 target price on the stock. Robert W. Baird began coverage on Sharps Compliance in a report on Wednesday, July 24th. They set a “buy” rating and a $4.50 target price on the stock. Zacks Investment Research downgraded Sharps Compliance from a “hold” rating to a “strong sell” rating in a report on Saturday, May 25th. Finally, Barrington Research reiterated a “buy” rating and set a $4.50 target price on shares of Sharps Compliance in a report on Tuesday, May 21st.



NASDAQ:SMED traded up $0.12 during mid-day trading on Friday, reaching $3.60. 405 shares of the company’s stock traded hands, compared to its average volume of 14,576. Sharps Compliance has a 12-month low of $2.97 and a 12-month high of $4.22. The firm has a market cap of $57.46 million, a price-to-earnings ratio of -89.88, a price-to-earnings-growth ratio of 1.60 and a beta of 0.24. The company has a debt-to-equity ratio of 0.04, a current ratio of 2.49 and a quick ratio of 1.95. The firm’s 50 day moving average is $3.62.

In related news, Director Parris H. Holmes, Jr. purchased 40,000 shares of the business’s stock in a transaction that occurred on Thursday, June 13th. The shares were bought at an average price of $3.31 per share, for a total transaction of $132,400.00. Following the purchase, the director now directly owns 942,027 shares of the company’s stock, valued at approximately $3,118,109.37. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders have acquired a total of 46,250 shares of company stock worth $153,075 in the last quarter. Company insiders own 20.70% of the company’s stock.

Several institutional investors have recently bought and sold shares of the stock. Quantum Capital Management grew its stake in shares of Sharps Compliance by 0.6% in the 1st quarter. Quantum Capital Management now owns 522,569 shares of the industrial products company’s stock worth $1,913,000 after buying an additional 3,223 shares during the last quarter. BlackRock Inc. grew its stake in shares of Sharps Compliance by 3.8% in the 2nd quarter. BlackRock Inc. now owns 108,739 shares of the industrial products company’s stock worth $387,000 after buying an additional 4,013 shares during the last quarter. Lapides Asset Management LLC grew its stake in shares of Sharps Compliance by 13.3% in the 2nd quarter. Lapides Asset Management LLC now owns 164,700 shares of the industrial products company’s stock worth $586,000 after buying an additional 19,300 shares during the last quarter. Wells Fargo & Company MN grew its stake in shares of Sharps Compliance by 8.3% in the 2nd quarter. Wells Fargo & Company MN now owns 424,814 shares of the industrial products company’s stock worth $1,512,000 after buying an additional 32,600 shares during the last quarter. Finally, Morgan Stanley grew its stake in shares of Sharps Compliance by 34.3% in the 2nd quarter. Morgan Stanley now owns 188,699 shares of the industrial products company’s stock worth $672,000 after buying an additional 48,199 shares during the last quarter. Institutional investors own 20.13% of the company’s stock.

About Sharps Compliance

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web-based compliance and training program.

Featured Story: Compound Annual Growth Rate (CAGR)

Get a free copy of the Zacks research report on Sharps Compliance (SMED)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Sharps Compliance (NASDAQ:SMED)

Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.